Unlock instant, AI-driven research and patent intelligence for your innovation.

Medicine composition for curing hepatitis

A technology of composition and medicine, which is applied in the field of pharmaceutical composition, can solve the problems of high price and achieve the effect of protecting against virus damage

Inactive Publication Date: 2003-03-05
广州瑞济生物技术有限公司
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there is still no effective method to cure hepatitis B and other hepatitis in medicine. The interferon and lamivudine commonly used in clinical practice are expensive, and can only inhibit part of the virus replication, and cannot prevent liver damage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] Mix flavescens extract 200mg, silymarin 80mg, microcrystalline cellulose 50mg, and Tween-80 5mg thoroughly, press into tablets, one tablet each time, three times a day.

Embodiment 2

[0015] Fully mix 200mg of oxymatrine, 80mg of silymarin, 50mg of lactose, and 5mg of Tween-80, and compress into tablets, one tablet each time, three times a day.

Embodiment 3

[0017] After mixing 200 mg of oxymatrine and 100 mg of hydroglucomethamine evenly, put it into a No. 1 capsule, and make one capsule each time, three times a day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The medicine composite capable of effectively inhibiting replication of hepatitis virus, protecting liver against fibrosis due to viral entry and necrosis of liver cells and curing hepatilis is composed of effective component extracted from flavescent sophora root and effective component extracted from silybum marianum according to the mixing ratio of 1:0.1-10:1.

Description

technical field [0001] The invention relates to a pharmaceutical composition, especially a composition containing active ingredients extracted from Sophora flavescens and milk thistle. Background technique [0002] Hepatitis is usually caused by viral infection. There are various clinical types such as A, B, C, and E. Hepatitis A belongs to acute hepatitis and has a sudden onset, but it is relatively easy to cure. Hepatitis B is the main liver disease currently plaguing our country. It has a high incidence in my country and is rapidly expanding. Although it can be effectively prevented through vaccination, it is difficult to cure infected patients, and vaccination cannot achieve lifelong immunity. , can still be infected when the antibody height is reduced. At present, in areas with a high incidence of hepatitis B, more than 10% of the population is infected with hepatitis B virus, and some of them have developed into hepatitis B, which seriously threatens the health of the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4545A61P1/16A61P31/12
Inventor 关世侠
Owner 广州瑞济生物技术有限公司